Post-approval studies (Phase 4)Ended earlyNCT01260649
What this trial is testing
N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression
Who this might be right for
Major Depressive Disorder
Massachusetts General Hospital 17